Editorial: RNA vaccines for prevalent and newly emerging diseases.

Autor: López-Camacho C; Nuffield Department of Medicine, The Jenner Institute, University of Oxford, Oxford, United Kingdom., Alameh MG; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States., Peer D; Laboratory of Precision NanoMedicine, The Shmunis School of Biomedicine and Cancer Research, Tel Aviv, Israel.; Department of Materials Sciences and Engineering, Iby and Aladar Fleischman Faculty of Engineering, Tel Aviv University, Tel Aviv, Israel.; Center for Nanoscience and Nanotechnology, Tel Aviv University, Tel Aviv, Israel.; Tel Aviv, Israel and Cancer Biology Research Center, Tel Aviv University, Tel Aviv, Israel., Culis P; Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, BC, Canada.
Jazyk: angličtina
Zdroj: Frontiers in immunology [Front Immunol] 2024 Aug 23; Vol. 15, pp. 1474260. Date of Electronic Publication: 2024 Aug 23 (Print Publication: 2024).
DOI: 10.3389/fimmu.2024.1474260
Abstrakt: Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Databáze: MEDLINE